BRKR

Bruker Corporation Healthcare - Medical Devices Investor Relations →

NO
6.6% ABOVE
↑ Moving away Was 6.0% last week
-15% -10% -5% 0% 5% 10% 15%+
Signal Threshold $57.79
14-Week RSI 60
Rel. Volume (14w) This week's trading vs. the 14-week average 1.2x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.18

Bruker Corporation (BRKR) closed at $61.59 as of 2026-11-13, trading 6.6% above its 200-week moving average of $57.79. The stock moved further from the line this week, up from 6.0% last week. The 14-week RSI sits at 60, indicating neutral momentum.

Trading volume is running at 1.2x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.18 ratio) is neutral — neither side is clearly dominating.

Over the past 1323 weeks of data, BRKR has crossed below its 200-week moving average 19 times. On average, these episodes lasted 22 weeks. Historically, investors who bought BRKR at the start of these episodes saw an average one-year return of +25.2%.

With a market cap of $9.4 billion, BRKR is a mid-cap stock. The company generates a free cash flow yield of 2.2%. Return on equity stands at -4.8%. The stock trades at 4.1x book value.

Share count has increased 3.5% over three years, indicating dilution.

Over the past 25.4 years, a hypothetical investment of $100 in BRKR would have grown to $416, compared to $979 for the S&P 500. BRKR has returned 5.8% annualized vs 9.4% for the index, underperforming the broader market over this period.

Free cash flow has been declining at a -54.3% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: BRKR vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After BRKR Crosses Below the Line?

Across 18 historical episodes, buying BRKR when it crossed below its 200-week moving average produced an average return of +32.3% after 12 months (median +29.0%), compared to +14.8% for the S&P 500 over the same periods. 82% of those episodes were profitable after one year. After 24 months, the average return was +62.5% vs +33.7% for the index.

Each line shows $100 invested at the moment BRKR crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices BRKR would reach each dislocation threshold.

Current Bean Score -0.19σ
Current FCF Yield 2.29%
Baseline Yield 2.23%
Historical σ 0.10pp

Dislocation Price Levels

Prices where BRKR's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-09-30).

LevelσPriceSignal
Deep Value+2σ$56.39Unusually cheap — analysis point
Value+1σ$58.65Cheap vs. own history
Fair Value+0σ$61.10Historical mean behavior
Expensive-1σ$63.76Expensive vs. own history
Deep Expensive-2σ$66.66Unusually expensive — analysis point

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Recent Earnings

DateEPS Est.EPS ActualSurprise
2026-11-04$0.42$0.56+34.6%
2026-08-04$0.38$0.49+27.5%
2026-05-06$0.23$0.31+34.8%
2026-02-12$0.65$0.59-9.8%
Data depth: 2 quarterly baselines, 19 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

21 / 13 weeks minimum

the write-ups I read Simply Wall St · Visual company reports and write-ups. Free tier covers five reports a month. referral

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are analysis points: prices at which the yield deviation becomes unusual enough to justify the work. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from BRKR's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

Yield Dislocation -0.49σ Dividend yield vs own 10-yr norm
Drawdown Score +0.13σ Distance from line vs own history
Sector-Relative -0.19σ Vs sector median this week
Buyback Acceleration -0.8pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity N/A TTM buys / market cap, percentile of buyers
FCF Yield vs History +0.8pp Vs own recent annual mean
Earnings Quality Improving Accrual gap trend (-3.4pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Historical Touches

BRKR has crossed below its 200-week MA 19 times with an average 1-year return of +25.2% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Jul 2001Oct 20011546.6%-71.8%+414.8%
Nov 2001Nov 200521181.2%-73.2%+238.7%
Jan 2006Jan 200615.8%+71.2%+1382.6%
Feb 2006Feb 200610.1%+74.2%+1317.3%
Feb 2006Mar 200610.9%+108.1%+1346.0%
Oct 2008Jun 20093255.6%+54.7%+833.9%
Jul 2009Jul 200910.3%+39.6%+695.4%
Nov 2011Nov 201128.0%+13.5%+436.7%
Dec 2011Jan 201232.1%+20.4%+424.0%
Jul 2012Sep 201268.1%+52.1%+448.6%
Oct 2012Nov 201249.9%+62.6%+425.3%
Aug 2015Oct 201576.5%+26.3%+261.3%
Oct 2016Oct 201612.7%+58.8%+218.4%
Sep 2022Oct 202239.2%+26.0%+18.2%
Sep 2023Sep 202310.7%+4.7%+1.6%
Oct 2023Nov 202367.8%+4.4%+0.6%
May 2024Jun 202610852.6%-43.8%-5.0%
Aug 2026Sep 202668.2%N/A+15.4%
Oct 2026Nov 202635.4%N/A+12.4%
Average22—+25.2%—

Frequently Asked Questions

Is BRKR below its 200-week moving average?

No. Bruker Corporation (BRKR) is currently 6.6% above its 200-week moving average of $57.79. It would need to fall to $57.79 to cross below the line.

What is BRKR's 200-week moving average price?

Bruker Corporation's 200-week moving average is $57.79 as of 2026-11-13. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when BRKR drops below its 200-week moving average?

BRKR has crossed below its 200-week moving average 19 times in our data. On average, buying at that moment produced a one-year return of +25.2%. These dips have historically been decent entry points. These episodes lasted 22 weeks on average.

Is BRKR a good value right now?

Here's what our data says about BRKR as of 2026-11-13: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 60. Free cash flow yield is 2.2%. Return on equity is -4.8%. Price-to-book is 4.1x. This is not a buy or sell recommendation — always do your own research.

How does BRKR compare to the S&P 500?

Over the past 25.4 years, $100 invested in BRKR would have grown to $416, compared to $979 for the S&P 500. That's 5.8% annualized vs 9.4% for the index. BRKR has underperformed the broader market over this period.

Does BRKR pay a dividend?

Yes. Bruker Corporation currently pays a dividend yield of 32.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-11-13